AJH801 Phase III Comparative Clinical Study in individuals with essential hypertension

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221447

Enrollment

600

Registered

2011-04-27

Start date

2011-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

investigational material(s) Generic name etc : AJH801 INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Oral

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In observation period -140 mmHg < the sitting SBP at trough < 199 mmHg - 90 mmHg < the sitting DBP at trough < 114 mmHg At the end of observation period -150 mmHg < the sitting SBP at trough < 199 mmHg - 95 mmHg < the sitting DBP at trough < 114 mmHg The difference in observation period -The difference between the sitting trough SBP at 2 points in observation period is within 30 mmHg. -The difference between the sitting trough DBP at 2 points in observation period is within 15 mmHg.

Exclusion criteria

Exclusion criteria: - Females who are pregnant, are breast-feeding, are potentially pregnant, are planning to be pregnant during the study period - Patients with secondary hypertension, or suspected of having secondary hypertension - Significant heart, renal, hepatic diseases or significant cerebrovascular disorder

Design outcomes

Primary

Measure	Time frame
Reduction of sitting SBP and DBP at trough from baseline	—

Secondary

Measure	Time frame
- Blood pressure change - Antihypertensive efficacy ratio - Blood pressure controlling ratio	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026